Psychedelics are going mainstream. The FDA has approved ketamine for certain patients with depression, and may soon approve MDMA for post-traumatic stress disorder (PTSD). But a fundamental question remains unclear: How do psychedelics work?
Gul Dolen is a professor of psychology and neuroscience at UC Berkeley. In a series of experiments, Gul has found evidence of a common mechanism that a wide range of psychedelics use to affect the brain. If Gul is correct, these drugs may be useful not only for people suffering from mental illness, but also for people dealing with neurological problems like strokes.
See omnystudio.com/listener for privacy information.
How to Start 40 Companies (and Counting)
The Cutting Edge of Energy Storage: Rust
The First Pig to Human Kidney Transplant
Designing a Drone That Delivers
Building Boundary-Breaking Balloons
Building a Robot That Can Walk the Walk
Building From the Ground Up: NNG Capital Fund
Can Your Phone Tell When You're Getting Sick?
The High-Stakes Quest to Reinvent Cement
How a Battery-Powered Stove Could Electrify America
3D Printing a Better Rocket
Using AI to Help Doctors Save Lives
Making Dam Good Hydropower
Using AI to Build Better Robots
Teaching Computers to See
Using Oil-Industry Tech to Create Clean Energy
Understanding Obesity and Alzheimer’s via Epigenomics
Reinventing the Restaurant
The Giant Torch That May Help Save the World
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Aligned Money Show
Gorse Culture PODcast : The H.R. Detective Agency!
HCI Leadership Revolution
The Ramsey Show
Planet Money